(19)
(11) EP 4 816 527 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24790834.6

(22) Date of filing: 02.10.2024
(51) International Patent Classification (IPC): 
C12N 9/12(2006.01)
C07K 7/06(2006.01)
 A61P 11/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 7/06; C07K 2319/10; C12N 9/12; C12Y 207/01154; A61P 11/00; C07K 7/08
(86) International application number:
PCT/EP2024/077764
(87) International publication number:
WO 2025/113859 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 29.11.2023 IT 202300025458

(71) Applicant: Kither Biotech S.r.l.
10126 Torino (IT)

(72) Inventors:
  • DELLA SALA, Angela
    10126 Torino (IT)
  • SALA, Valentina
    10060 Roletto (Torino) (IT)
  • HIRSCH, Emilio
    10125 Torino (IT)
  • GHIGO, Alessandra
    12038 Savigliano (Cuneo) (IT)

(74) Representative: Buzzi, Notaro & Antonielli d'Oulx S.p.A. 
Corso Vittorio Emanuele II, 6
10123 Torino
10123 Torino (IT)

   


(54) NON-NATURAL PEPTIDES TARGETING THE SCAFFOLD ACTIVITY OF PI3K-GAMMA AND THERAPEUTIC USES THEREOF